438 related articles for article (PubMed ID: 24772414)
21. Polymeric nanoparticles for cancer therapy.
Parveen S; Sahoo SK
J Drug Target; 2008 Feb; 16(2):108-23. PubMed ID: 18274932
[TBL] [Abstract][Full Text] [Related]
22. Polymeric nanoparticles as carrier for targeted and controlled delivery of anticancer agents.
Taghipour-Sabzevar V; Sharifi T; Moghaddam MM
Ther Deliv; 2019 Aug; 10(8):527-550. PubMed ID: 31496433
[TBL] [Abstract][Full Text] [Related]
23. Nanoscale Polymersomes as Anti-Cancer Drug Carriers Applied for Pharmaceutical Delivery.
Tuguntaev RG; Okeke CI; Xu J; Li C; Wang PC; Liang XJ
Curr Pharm Des; 2016; 22(19):2857-65. PubMed ID: 26898733
[TBL] [Abstract][Full Text] [Related]
24. Albumin-Based Nanodevices as Drug Carriers.
Loureiro A; Azoia NG; Gomes AC; Cavaco-Paulo A
Curr Pharm Des; 2016; 22(10):1371-90. PubMed ID: 26806342
[TBL] [Abstract][Full Text] [Related]
25. Lipid-coated polymeric nanoparticles for cancer drug delivery.
Krishnamurthy S; Vaiyapuri R; Zhang L; Chan JM
Biomater Sci; 2015 Jul; 3(7):923-36. PubMed ID: 26221931
[TBL] [Abstract][Full Text] [Related]
26. Natural Polymeric Nanoparticles for Brain-Targeting: Implications on Drug and Gene Delivery.
Elzoghby AO; Abd-Elwakil MM; Abd-Elsalam K; Elsayed MT; Hashem Y; Mohamed O
Curr Pharm Des; 2016; 22(22):3305-23. PubMed ID: 26845323
[TBL] [Abstract][Full Text] [Related]
27. Natural low- and high-density lipoproteins as mighty bio-nanocarriers for anticancer drug delivery.
Mahmoudian M; Salatin S; Khosroushahi AY
Cancer Chemother Pharmacol; 2018 Sep; 82(3):371-382. PubMed ID: 29915981
[TBL] [Abstract][Full Text] [Related]
28. Polymersomes and their applications in cancer delivery and therapy.
Guan L; Rizzello L; Battaglia G
Nanomedicine (Lond); 2015; 10(17):2757-80. PubMed ID: 26328898
[TBL] [Abstract][Full Text] [Related]
29. Calcium phosphate nanocarriers for drug delivery to tumors: imaging, therapy and theranostics.
Huang D; He B; Mi P
Biomater Sci; 2019 Oct; 7(10):3942-3960. PubMed ID: 31414096
[TBL] [Abstract][Full Text] [Related]
30. Protein nanoparticles as drug delivery systems for cancer theranostics.
Hua Y; Qin Z; Gao L; Zhou M; Xue Y; Li Y; Xie J
J Control Release; 2024 Jul; 371():429-444. PubMed ID: 38849096
[TBL] [Abstract][Full Text] [Related]
31. Silk fibroin nanoparticle as a novel drug delivery system.
Mottaghitalab F; Farokhi M; Shokrgozar MA; Atyabi F; Hosseinkhani H
J Control Release; 2015 May; 206():161-76. PubMed ID: 25797561
[TBL] [Abstract][Full Text] [Related]
32. Self-assembled nanoplatform for targeted delivery of chemotherapy agents via affinity-regulated molecular interactions.
Park S; Kang S; Veach AJ; Vedvyas Y; Zarnegar R; Kim JY; Jin MM
Biomaterials; 2010 Oct; 31(30):7766-75. PubMed ID: 20667589
[TBL] [Abstract][Full Text] [Related]
33. PPy@MIL-100 Nanoparticles as a pH- and Near-IR-Irradiation-Responsive Drug Carrier for Simultaneous Photothermal Therapy and Chemotherapy of Cancer Cells.
Zhu YD; Chen SP; Zhao H; Yang Y; Chen XQ; Sun J; Fan HS; Zhang XD
ACS Appl Mater Interfaces; 2016 Dec; 8(50):34209-34217. PubMed ID: 27998104
[TBL] [Abstract][Full Text] [Related]
34. Dual nanoparticle drug delivery: the future of anticancer therapies?
King MR; Mohamed ZJ
Nanomedicine (Lond); 2017 Jan; 12(2):95-98. PubMed ID: 27885896
[No Abstract] [Full Text] [Related]
35. Tumor Targeting of Polymeric Nanoparticles Conjugated with Peptides, Saccharides, and Small Molecules for Anticancer Drugs.
Bayram B; Ozgur A; Tutar L; Tutar Y
Curr Pharm Des; 2017; 23(35):5349-5357. PubMed ID: 28911307
[TBL] [Abstract][Full Text] [Related]
36. A critical review of lipid-based nanoparticles for taxane delivery.
Feng L; Mumper RJ
Cancer Lett; 2013 Jul; 334(2):157-75. PubMed ID: 22796606
[TBL] [Abstract][Full Text] [Related]
37. Chitosan-modified nanocarriers as carriers for anticancer drug delivery: Promises and hurdles.
Alhodieb FS; Barkat MA; Barkat HA; Hadi HA; Khan MI; Ashfaq F; Rahman MA; Hassan MZ; Alanezi AA
Int J Biol Macromol; 2022 Sep; 217():457-469. PubMed ID: 35798082
[TBL] [Abstract][Full Text] [Related]
38. Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications.
Galvin P; Thompson D; Ryan KB; McCarthy A; Moore AC; Burke CS; Dyson M; Maccraith BD; Gun'ko YK; Byrne MT; Volkov Y; Keely C; Keehan E; Howe M; Duffy C; MacLoughlin R
Cell Mol Life Sci; 2012 Feb; 69(3):389-404. PubMed ID: 22015612
[TBL] [Abstract][Full Text] [Related]
39. New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma.
Turato C; Balasso A; Carloni V; Tiribelli C; Mastrotto F; Mazzocca A; Pontisso P
J Control Release; 2017 Dec; 268():184-197. PubMed ID: 29051062
[TBL] [Abstract][Full Text] [Related]
40. Cyclodextrin-based Polymeric Nanoparticles as Efficient Carriers for Anticancer Drugs.
Duchene D; Cavalli R; Gref R
Curr Pharm Biotechnol; 2016; 17(3):248-55. PubMed ID: 26517333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
